Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 10:13:1037467.
doi: 10.3389/fmicb.2022.1037467. eCollection 2022.

Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2

Affiliations
Review

Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2

Alef Aragão Carneiro Dos Santos et al. Front Microbiol. .

Abstract

Coronavirus disease 2019 (COVID-19) is triggered by the SARS-CoV-2, which is able to infect and cause dysfunction not only in lungs, but also in multiple organs, including central nervous system, skeletal muscle, kidneys, heart, liver, and intestine. Several metabolic disturbances are associated with cell damage or tissue injury, but the mechanisms involved are not yet fully elucidated. Some potential mechanisms involved in the COVID-19-induced tissue dysfunction are proposed, such as: (a) High expression and levels of proinflammatory cytokines, including TNF-α IL-6, IL-1β, INF-α and INF-β, increasing the systemic and tissue inflammatory state; (b) Induction of oxidative stress due to redox imbalance, resulting in cell injury or death induced by elevated production of reactive oxygen species; and (c) Deregulation of the renin-angiotensin-aldosterone system, exacerbating the inflammatory and oxidative stress responses. In this review, we discuss the main metabolic disturbances observed in different target tissues of SARS-CoV-2 and the potential mechanisms involved in these changes associated with the tissue dysfunction.

Keywords: SARS-CoV-2; inflammation; metabolism; oxidative stress; renin-angiotensin-aldosterone system.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
SARS-CoV-2-induced metabolic disturbances in central nervous system. CNS, central nervous system.
Figure 2
Figure 2
SARS-CoV-2-induced metabolic disturbances in skeletal muscle. AT1R, angiotensin II type 1 receptor; FA, fatty acid; HIF-1α, hypoxia-inducible factor-1 alpha; RAAS, renin-angiotensin-aldosterone system; ROS, reactive oxygen species.
Figure 3
Figure 3
SARS-CoV-2-induced metabolic disturbances in kidneys. FA, fatty acid; HIF-1α, hypoxia-inducible factor-1 alpha; RAAS, renin-angiotensin-aldosterone system; ROS, reactive oxygen species.
Figure 4
Figure 4
SARS-CoV-2-induced metabolic disturbances in heart. ATP adenosine triphosphate; CRP, C-reactive protein; ETC, electron transport chain; FA, fatty acid.
Figure 5
Figure 5
SARS-CoV-2-induced metabolic disturbances in liver. ROS, reactive oxygen species.
Figure 6
Figure 6
SARS-CoV-2-induced metabolic disturbances in gastrointestinal system. LPS, lipopolysaccharide.
Figure 7
Figure 7
Key points of the effects of SARS-CoV-2 on cell metabolism an tissue/organ dysfunction. ATP adenosine triphosphate; HIF-1α, hypoxia-inducible factor-1 alpha; RAAS, renin-angiotensin-aldosterone system; ROS, reactive oxygen species.

Similar articles

Cited by

References

    1. Abdi A., Jalilian M., Sarbarzeh P. A., Vlaisavljevic Z. (2020). Diabetes and COVID-19: A systematic review on the current evidences. Diabetes Res. Clin. Pract. 166:108347. doi: 10.1016/j.diabres.2020.108347, PMID: - DOI - PMC - PubMed
    1. Abdullahi A., Candan S. A., Abba M. A., Bello A. H., Alshehri M. A., Afamefuna Victor E., et al. . (2020). Neurological and musculoskeletal features of COVID-19: A systematic review and meta-analysis. Front. Neurol. 11:687. doi: 10.3389/fneur.2020.00687, PMID: - DOI - PMC - PubMed
    1. Aiyegbusi O. L., Hughes S. E., Turner G., Rivera S. C., Mcmullan C., Chandan J. S., et al. . (2021). Symptoms, complications and management of long COVID: a review. J. R. Soc. Med. 114, 428–442. doi: 10.1177/01410768211032850, PMID: - DOI - PMC - PubMed
    1. Akarsu C., Karabulut M., Aydin H., Sahbaz N. A., Dural A. C., Yegul D., et al. . (2022). Association between acute pancreatitis and COVID-19: could pancreatitis be the missing piece of the puzzle about increased mortality rates? J. Investig. Surg. 35, 119–125. doi: 10.1080/08941939.2020.1833263, PMID: - DOI - PubMed
    1. Aksu U., Demirci C., Ince C. (2011). The pathogenesis of acute kidney injury and the toxic triangle of oxygen, reactive oxygen species and nitric oxide. Contrib. Nephrol. 174, 119–128. doi: 10.1159/000329249, PMID: - DOI - PubMed